KONSTANTIN "Gus" KOUSOULAS
Louisiana State University
H-index: 53
North America-United States
Top articles of KONSTANTIN "Gus" KOUSOULAS
Oncolytic hsv-1 (vc2) gm-csf regulates the proinflammatory profile suggestive of an immunomodulatory effect in PDAC cells
Cancer Research
2024/3/22
Herpes simplex virus type 1 derived influenza vaccine
2024/2/15
Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice
Journal of Medical Virology
2024/1
Spike protein vaccine triggers systemic Th2 and Th17 inflammatory responses and pulmonary immunopathology following SARS-CoV-2 breakthrough infection
The Journal of Immunology
2023/5/1
176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice
Journal of Investigative Dermatology
2023/5/1
Effect of stimulator of interferon genes (STING) signaling on radiation-induced chemokine expression in human osteosarcoma cells
Plos one
2023/4/20
Inactivation of the UL37 Deamidase Enhances Virus Replication and Spread of the HSV-1 (VC2) Oncolytic Vaccine Strain and Secretion of GM-CSF
Viruses
2023/1/27
Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation
Frontiers in immunology
2023/1/18
Unlocking the potential of kinase targets in cancer: insights from CancerOmicsNet, an AI-driven approach to drug response prediction in cancer
Cancers
2023/8/10
The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro …
Frontiers in Molecular Biosciences
2023/6/14
Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors
BMC cancer
2022/11/24
Activating transcription factor 6 protects against endothelial barrier dysfunction
Cellular signalling
2022/11/1
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G
Vaccine
2022/10/6
Predicted Structure and Functions of the Prototypic Alphaherpesvirus Herpes Simplex Virus Type-1 UL37 Tegument Protein
Viruses
2022/10/4
Vaccines against genital herpes simplex infections
2022/8/4
Oncolytic virotherapy with the HSV-1 (VC2) vaccine strain induces anti-tumor T-cell responses in the murine 4T1 breast cancer model
Cancer Research
2022/6/15
Prospects for personalized cancer vaccines: The oncolytic and immunotherapeutic HSV-1 (VC2) virus expressing an ovalbumin (OVA) antigen elicits robust anti-OVA immune responses
Cancer Research
2022/6/15
An attenuated HSV-1-derived malaria vaccine expressing liver-stage exported proteins induces sterilizing protection against infectious sporozoite challenge
Vaccines
2022/2/16
Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines
Frontiers in molecular biosciences
2022/1/26